44 results
8-K
EX-10.1
SLNO
Soleno Therapeutics, Inc.
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
, or its employees (or Persons it currently intends to hire) made prior to their employment by the Company, except for technology that is licensed
424B5
SLNO
Soleno Therapeutics, Inc.
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and avoid third-party patent interference or patent infringement claims; and
attract, hire and retain qualified personnel.
In addition, because … an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical
424B5
SLNO
Soleno Therapeutics, Inc.
27 Sep 23
Prospectus supplement for primary offering
5:26pm
property rights and avoid third-party patent interference or patent infringement claims; and
attract, hire and retain qualified personnel.
In addition … do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience
8-K
EX-10.1
q94ejdw
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
tywl5u6rx7th951jq3a
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
xiy0trbjnjsaj8
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
7u2yrw nf6yn
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
jn0mw8bg1mpq8i
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
imv4o9
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
yqikhqscoledmghw4xv
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
6rtoidf a2z
12 Apr 19
Prospectus supplement
4:41pm